AstraZeneca PLCAZN

Is AZN cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$174.40+4.89 (+2.88%)24:00 UTC
NYSEHealthcare

Company snapshot

Market Cap
$272B
Mega-cap
+243%
2016 — today
10-Year Price
+178%
2016 — today
52-Week Range
$155.62$209.48
Current $174.40· 35%

AstraZeneca discovers, develops, manufactures, and commercializes prescription medicines globally. Its portfolio addresses cardiovascular, renal, metabolic, and oncological conditions, alongside rare diseases and COVID-19 solutions like Tagrisso, Farxiga, Symbicort, and Soliris. Operating worldwide, the firm drives innovation through strategic collaborations with partners like Neurimmune, BenevolentAI, Lunit, and Absci. Formed in 1992 as Zeneca Group, it rebranded in 1999 and is based in Cambridge, UK.

Similar companies

Healthcare companies of comparable size to AZN
CompanyP/EDiv yield
TMOThermo Fisher Scientific Inc.37.40.3%
AMGNAmgen Inc.28.62.2%
NVSNovartis AG30.72.9%
GILDGilead Sciences, Inc.-52.42.0%
MRKMerck & Co., Inc.117.12.3%
UNHUnitedHealth Group Incorporated23.52.2%
ABTAbbott Laboratories38.72.4%
NVONovo Nordisk A/S10.04.6%

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
26.2
Historically cheap
Historically cheap relative to the last 10 years
Sector median 25.2in line with sector
P/B ratio
5.4
Below average
Below the 10-year average
Sector median 2.2above sector
EV / EBITDA
14.5
Historically cheap
Historically cheap relative to the last 10 years
Sector median 15.7in line with sector
Dividend Yield
1.9%
Near historic low
Near historic low — last 10 years
Sector median 1.8%in line with sector
PEG ratio
0.7
Near historic low
Near historic low — last 10 years
Sector median 1.8below sector
FCF Yield
3.2%
Above average
Above the 10-year average
Sector median -12.6%above sector
Free · No credit card needed

Get alerted when AZN is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.